Indication
Splenectomy
5 clinical trials
9 products
2 drugs
Clinical trial
Apixaban for Prevention of Portal Vein Thrombosis in Liver Cirrhotic Patients After Laparoscopic Splenectomy and Azygoportal Disconnection for Portal HypertensionStatus: Completed, Estimated PCD: 2023-05-31
Product
ApixabanProduct
DipyridamoleProduct
Low Molecular Weight HeparinClinical trial
Efficacy and Safety of Apixaban, Warfarin and Aspirin Anticoagulation for Prevention of Portal Vein Thrombosis in Liver Cirrhotic Patients After Laparoscopic SplenectomyStatus: Completed, Estimated PCD: 2023-03-31
Drug
RivaroxabanProduct
WarfarinDrug
AspirinProduct
Low molecular weight heparinClinical trial
Comparing the Analgesic Effects of Different Doses of Dexmedetomidine as an Adjuvant in External Oblique Intercostal Plane Block in Splenectomy: A Randomized TrialStatus: Not yet recruiting, Estimated PCD: 2024-10-01
Product
DexmedetomidineClinical trial
Immunogenicity and Safety of a Meningococcal Serogroup B Vaccine in Adult Patients With AspleniaStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Product
BexseroClinical trial
Multicenter, Randomized, Phase III, Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With AspleniaStatus: Recruiting, Estimated PCD: 2028-09-01
Product
Trumenba®Product
Bexsero®